v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Nov. 30, 2020 $ 290,269 $ 39 $ 393,841 $ 87 $ (103,698)
Beginning Balance, Shares at Nov. 30, 2020   38,864,872      
Exercise of stock options 394   394    
Exercise of stock options, Shares   190,825      
Repurchase of unvested early exercised stock options, Shares   (971)      
Vesting of early-exercised stock options 40   40    
Issuance under employee stock purchase plan 1,043   1,043    
Issuance under employee stock purchase plan, Shares   64,589      
Stock-based compensation 2,700   2,700    
Unrealized loss on available-for-sale securities (38)     (38)  
Net loss (24,275)       (24,275)
Ending Balance at Feb. 28, 2021 270,133 $ 39 398,018 49 (127,973)
Ending Balance, Shares at Feb. 28, 2021   39,119,315      
Beginning Balance at Nov. 30, 2020 290,269 $ 39 393,841 87 (103,698)
Beginning Balance, Shares at Nov. 30, 2020   38,864,872      
Net loss (79,492)        
Ending Balance at Aug. 31, 2021 375,217 $ 45 558,421 (59) (183,190)
Ending Balance, Shares at Aug. 31, 2021   44,556,604      
Beginning Balance at Feb. 28, 2021 270,133 $ 39 398,018 49 (127,973)
Beginning Balance, Shares at Feb. 28, 2021   39,119,315      
Issuance of common stock, net of offering\ issuance costs 150,157 $ 5 150,152    
Issuance of common stock, net of offering\ issuance costs, Shares   5,175,000      
Exercise of stock options 241   241    
Exercise of stock options, Shares   109,232      
Vesting of early-exercised stock options 104   104    
Stock-based compensation 3,944   3,944    
Unrealized loss on available-for-sale securities (19)     (19)  
Net loss (26,382)       (26,382)
Ending Balance at May. 31, 2021 398,178 $ 44 552,459 30 (154,355)
Ending Balance, Shares at May. 31, 2021   44,403,547      
Exercise of stock options 584 $ 1 583    
Exercise of stock options, Shares   114,182      
Vesting of early-exercised stock options 49   49    
Issuance under employee stock purchase plan 1,017   1,017    
Issuance under employee stock purchase plan, Shares   38,875      
Stock-based compensation 4,313   4,313    
Unrealized loss on available-for-sale securities (89)     (89)  
Net loss (28,835)       (28,835)
Ending Balance at Aug. 31, 2021 375,217 $ 45 558,421 (59) (183,190)
Ending Balance, Shares at Aug. 31, 2021   44,556,604      
Beginning Balance at Nov. 30, 2021 342,302 $ 45 563,757 (608) (220,892)
Beginning Balance, Shares at Nov. 30, 2021   44,664,371      
Exercise of stock options 424   424    
Exercise of stock options, Shares   117,870      
Vesting of early-exercised stock options 47   47    
Issuance under employee stock purchase plan 1,064   1,064    
Issuance under employee stock purchase plan, Shares   71,207      
Stock-based compensation 6,071   6,071    
Unrealized loss on available-for-sale securities (1,458)     (1,458)  
Net loss (42,533)       (42,533)
Ending Balance at Feb. 28, 2022 305,917 $ 45 571,363 (2,066) (263,425)
Ending Balance, Shares at Feb. 28, 2022   44,853,448      
Beginning Balance at Nov. 30, 2021 342,302 $ 45 563,757 (608) (220,892)
Beginning Balance, Shares at Nov. 30, 2021   44,664,371      
Net loss (133,643)        
Ending Balance at Aug. 31, 2022 342,545 $ 47 700,775 (3,742) (354,535)
Ending Balance, Shares at Aug. 31, 2022   47,147,781      
Beginning Balance at Feb. 28, 2022 305,917 $ 45 571,363 (2,066) (263,425)
Beginning Balance, Shares at Feb. 28, 2022   44,853,448      
Exercise of stock options 432   432    
Exercise of stock options, Shares   173,155      
Vesting of restricted stock units, Shares   13,465      
Vesting of early-exercised stock options 35   35    
Stock-based compensation 6,775   6,775    
Unrealized loss on available-for-sale securities (1,019)     (1,019)  
Net loss (45,401)       (45,401)
Ending Balance at May. 31, 2022 266,739 $ 45 578,605 (3,085) (308,826)
Ending Balance, Shares at May. 31, 2022   45,040,068      
Issuance of pre-funded warrants, net of issuance costs of $234 94,759   94,759    
Issuance of common stock, net of offering\ issuance costs 19,328 $ 2 19,326    
Issuance of common stock, net of offering\ issuance costs, Shares   2,000,000      
Exercise of stock options 174   174    
Exercise of stock options, Shares   24,147      
Vesting of restricted stock units, Shares   18,469      
Vesting of early-exercised stock options 32   32    
Issuance under employee stock purchase plan 891   891    
Issuance under employee stock purchase plan, Shares   65,097      
Stock-based compensation 6,988   6,988    
Unrealized loss on available-for-sale securities (657)     (657)  
Net loss (45,709)       (45,709)
Ending Balance at Aug. 31, 2022 $ 342,545 $ 47 $ 700,775 $ (3,742) $ (354,535)
Ending Balance, Shares at Aug. 31, 2022   47,147,781